Lacosamide is a novel antiepileptic drug approved as adjunctive treatment of refractory
partial-onset epilepsy in patients 17 years of age or older.1 Lacosamide is a functionalized
amino acid compound that, in adults, has 100% oral absorption with linear pharmacokinetics,
low protein binding (